NCT01416350 - A Single and Repeat Dose PK/PD Study to Characterise Biomarker Response in Healthy Subjects Treated With Azithromycin | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 30, 2011

Primary Completion Date

May 12, 2011

Study Completion Date

May 12, 2011

Conditions

Autoimmune Diseases

Interventions

DRUG

Azithromycin - 250 mg

Part A - A single azithromycin dose of 250 mg.

DRUG

Azithromycin - 1000 mg

Part A - A single azithromycin dose of 1000 mg.

DRUG

Azithromycin - 250 mg every other day for 3 weeks

Part B - Repeat dose study treating subjects with Azithromycin (250 mg every other day for 3 weeks), the dose approximates that used in the treatment of chronic neutrophil-related inflammatory conditions.

Trial Locations (1)

NW10 7EW

GSK Investigational Site, London